Business
Pandemic winners and losers: We check in on 9 stocks that have had quite a ride

Pandemic winners and losers: We check in on 9 stocks that have had quite a ride

Last year, much was made of the "lockdown winners" in the stock market. As soon as it became clear we would all be inside for the foreseeable future, markets and investors tried to quickly adjust to what would be the "new normal".

We've selected 9 stocks that have had an interesting time of it, checking in on where their share prices are now.

The good

Some stocks boomed, and then kept booming. Etsy, the online marketplace for vintage gifts and homemade crafts saw its share price rise during the early days of the pandemic — and they haven't looked back since, gaining 555% since 2020. DocuSign, which lets organizations manage contracts and agreements electronically (no need to sign in-person), has also had a pretty smooth ride, up 257%.

But no company was the face of "pandemic winner" more than Zoom. The video-conferencing site has seen the shine come off pretty dramatically since last year, as expectations got ahead of the company's economic reality, but even so it's hard to put Zoom in any other bucket than "the pandemic was good for business".

The bad, then good

Few sectors got hit as hard as travel. Online travel company Expedia saw its shares shed almost 60% of their value, but they've since made a roaring comeback, as lockdowns have faded and we booked all those vacations we missed out on. Airbnb had a similar experience, going through a brutal restructuring for its employees, before business picked up and the company managed to get its IPO done. Since then it's up 38%.

Live Nation Entertainment, which is the parent company of Ticketmaster and other live event platforms, also managed to weather the storm, gaining 57% since the start of 2020, despite the turbulence of the early pandemic.

The ugly

Airlines, like American Airlines and Delta, still aren't back to where they started, with many taking on debt or issuing equity to get them through the tough times of reduced air travel. Then there's Peloton, which has done an even more extreme version of Zoom. Technically, shares are still up 60% on where they were at the start of 2020, but with everything moving in the wrong direction at their recent results, and the company still burning cash, that might not last.

More Business

See all Business
business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.